WhiteOak Capital Pharma and Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.48%)Nav, as on 18-07-2025

  • Previous Nav

  • Net Change on 18-07-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
BSE SENSEX - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 13.07 24.53 21.59 1.80 8,569.15
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 19.49 29.01 24.12 1.89 5,727.59
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 19.84 28.42 23.67 1.93 3,849.24
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 13.55 26.05 23.11 1.93 3,056.90
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 14.94 23.53 22.11 1.93 2,785.12

Fund Holdings as on 30-June-2025

  • Max Healthcare Institute Limited

  • Sun Pharmaceutical Industries Limited

  • Divi's Laboratories Limited

  • Fortis Healthcare Limited

  • Cipla Limited

  • Laurus Labs Limited

  • Krishna Institute Of Medical Sciences Limited

  • Torrent Pharmaceuticals Limited

  • Clearing Corporation of India Ltd

  • Lupin Limited

  • Apollo Hospitals Enterprise Limited

  • Eris Lifesciences Limited

  • Abbott India Limited

  • Gland Pharma Limited

  • Emcure Pharmaceuticals Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Glenmark Pharmaceuticals Limited

  • Kovai Medical Center and Hospital Limited

  • Ajanta Pharma Limited

  • Pfizer Limited

  • Shaily Engineering Plastics Limited

  • Neuland Laboratories Limited

  • Jupiter Life Line Hospitals Limited

  • Thyrocare Technologies Limited

  • Alembic Pharmaceuticals Limited

  • Acutaas Chemicals Limited

  • Net Receivables / (Payables)

  • RPG Life Sciences Limited

  • Strides Pharma Science Limited

  • 91 Days Tbill (MD 11/07/2025)

  • FDC Limited

  • Rainbow Childrens Medicare Limited

  • Sai Life Sciences Limited

  • AstraZeneca Pharma India Limited

  • 91 Days Tbill (MD 01/08/2025)

  • Supriya Lifescience Limited

  • Shilpa Medicare Limited

  • Onesource Specialty Pharma Limited

  • Laxmi Dental Limited

  • Navin Fluorine International Limited

  • PB Fintech Limited

  • Dr.Agarwals Eye Hospital Limited

  • 182 Days Tbill (MD 04/09/2025)

  • Jubilant Ingrevia Limited

  • Vijaya Diagnostic Centre Limited

  • Aster DM Healthcare Limited

  • Poly Medicure Limited

  • 364 Days Tbill (MD 28/08/2025)

  • 91 Days Tbill (MD 25/09/2025)

  • Dr. Reddy's Laboratories Limited

  • 182 Days Tbill (MD 07/08/2025)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Plastic Products

  • Chemicals

  • Medical Equipment/Supplies/Accessories

  • Fintech

View More

Fund Manager

  • Cash

  • Equity

  • Sovereign

View More

About WhiteOak Capital Pharma and Healthcare Fund

Scheme Analysis

WhiteOak Capital Pharma and Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to WhiteOak Capital Mutual Fund. It was launched on 06-Feb-2024 and currently has an AUM of ₹364.10 crore. WhiteOak Capital Pharma and Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of WhiteOak Capital Pharma and Healthcare Fund ended down ₹-0.07(-0.48%)yesterday to ₹13.855.

Among its top 3 holdings the fund has exposure to Max Healthcare Institute Limited, and

The WhiteOak Capital Pharma and Healthcare Fund is managed by Piyush Baranwal and Ramesh Mantri.

Fund House Contact

Unit No. B4, 6th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025

022-6918 7607
022 69187643